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Background: Fine needle aspiration biopsy is usually performed to evaluate thyroid lesions. The purpose of this
study was to evaluate the usefulness of diffusion weighted imaging to differentiate malignancy of thyroid lesions.
Methods: The study was approved by ethics committee of Shanghai Changzheng Hospital.Forty-two patients,
10 men and 32 women (range: 20–72 years, mean age 42.4 years) with thyroid lesions were included in the study.
Routine neck MR and diffusion-weighted MR imaging was performed using multiple b-values. ADC values were
computed for the different b-values. Histological results of the thyroidectomy samples were obtained for all the
patients. ADC values of benign and malignant thyroid lesions were compared with the pathology results. Logistic
regression analysis was used to detect independent parameters for differentiating benign and malignancy of lesions.
Result: Based on the histology results there were 28 benign and 14 malignant cases. The difference of ADC value
between benign and malignant thyroid lesions was significant for ADC values obtained using b-values of 0 and 300 s/
mm2 (p < 0.001). The ADC values were significantly higher in benign lesions (benign ADC: 2.37 ± 0.47 × 10-3 mm2/s vs.
malignant: 1.49 ± 0.60 × 10-3 mm2/s). ADC values obtained with b-values of 0 and 300 mm2/s and max nodular diameter
was regarded as the two most discriminative parameters for differentiating malignancy. Using the pathology results as a
standard reference, area under ROC curve was found to be 0.876 for an ADC cutoff value of 2.17 × 10-3 mm2/s that
corresponded to an acquisition with b-values of 0 and 300 mm2/s.
Conclusion: Diffusion-weighted MR imaging is a promising non-invasive method to differentiate malignancy in thyroid
lesions.
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Incidence and prevalence of thyroid disease has seen a
great increase in recent years. An increasing incidence of
thyroid cancer has been reported worldwide [1-3]. The
reported incidence of thyroid cancer is up to 0.07% over
the past 30 years [4]. 44,670 new cases and 1,690 deaths
were attributed to thyroid cancer in 2010 [5]. Fine needle
aspiration biopsy (FNAB) is regarded as the standard
reference for diagnosis, but it has been reported before
that FNAB results may mimic some other diseases [6-8].* Correspondence: cjr.taoxiaofeng@vip.163.com
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reproduction in any medium, provided the orUltrasound is the most common non-invasive and sensitive
diagnostic imaging modality for diagnosing thyroid lesions,
but there are still no reliable criteria for distinguishing
benign from malignant lesions. In addition, it is difficult to
access the malignancy of the nodule when it is large or
multinodular [9]. Despite tremendous improvement in
diagnostic techniques such as ultrasound, radionuclide
imaging and CT, there is still a big challenge to have a
non-invasive and reliable technique to differentiate benign
from malignant lesions. Recent developments in MRI may
show that some MR protocols are of diagnostic value for
these types of lesions [10]. Routine T1- and T2-weighted
MR imaging can provide information on the location and
size of thyroid lesions. But these protocols still don’t have. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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nodules or assessing the functional status of these thyroid
nodules.
Diffusion-weighted MR imaging (DWI) is an emerging
technique for central nervous system (CNS) diseases. DWI
is sensitive to changes in the microstructural organization
of tissue that may affect water diffusion. It has been used
in various forms to evaluate head and neck tumors
[11-13]. The Apparent Diffusion Coefficient (ADC) value,
a metric obtained from DWI scans, could be a quantita-
tive parameter for distinguishing malignant tumors from
benign lesions.
In our current study, we compared ADC values of
thyroid lesions with their pathology reports in order to
evaluate its usefulness for distinguishing malignancy.
Methods
Patient selection
Between July 2007 and Jan 2011, 42 patients (10 male;
32 female) with palpable or ultrasonography determined
thyroid nodules were prospectively enrolled and patient
consent was obtained. The study was approved by ethics
committee of Shanghai Changzheng Hospital. Mean age
of those patients was 42.9 yrs (range 20-72 yrs). Routine
neck MR imaging and diffusion-weighted MR imaging
was performed for each patient. All patients enrolled for
this study have been scheduled to have thyroidectomy
within 2 weeks. Thyroidectomy was performed after-
wards and pathology results were obtained for each
patient. Conventional histology revealed that 28 patients
had benign lesions, including thyroid adenoma (N = 20),
nodular goiter (N = 5), and Hashimoto's thyroiditis (N = 3)
while 14 patients were found to have malignant lesions,
including thyroid papillary carcinoma (N = 10), follicu-
lar thyroid cancer (N = 3), atypical hyperplasia (N = 1).
Thyroid lesions less than 1 cm were excluded because
of diagnostic difficulties in evaluation.
MRI protocol
MR scanning was performed on GE Signa HD 1.5 T MR
scanner (GE healthcare, USA). Routine MRI examina-
tions were done with the following parameters: fast spin
echo FSE scanning for neck, axial T1WI (TR = 520 ms,
TE = 14 ms), T2WI (TR = 3500 ms, TE = 95 ms) and
coronal T2WI (TR = 3000 ms, TE = 85 ms). Thickness =
4 mm, Spacing = 1 mm. FOV = 14 cm × 14 cm, Matrix =
320 × 256, NEX = 4.
Diffusion Weighted MR Imaging (DWI) was acquired
using four different b factors (0, 300, 500, and 800 s/mm2)
in a STIR fat suppressed SE-EPI sequence. All DWI scans
were acquired with the same parameters:TR = 3000 ms,
TE = 60 ms, Matrix = 96 × 128, thickness - 4 mm and 6
averages were obtained. Total scanning time of about
10 minutes for the DWI scan.Image post processing
Using the post processing software Functool from GE,
ADC maps were automatically generated for each of the
b factors. ADC values were extracted from ADC maps.
Circular ROIs (regions of interests)with an area of 1 cm2
were carefully placed on the lesions (areas of necrosis,
hemorrhage, calcium and cyst formation were excluded).
ROIs were placed on one ADC map and then propa-
gated to the other 2 by two experienced radiologists
blinded to each other’s delineations. To minimize noise,
each radiologist made three measurements for each le-
sion and the mean ADC value was recorded. Interrater
reliability of the ROIs ADC values had ICC > 0.87. Final
ADC value was determined by the mean values from
two raters.
Analysis
ADC maps were computed for each of the b-values used
in the DWI protocol. This was done automatically for the
b-factors of 300 s/mm2, 500 s/mm2 and 800 s/mm2. ADC
values were extracted from the ADC maps. Statistical ana-
lysis was performed using the Statistical Package for the
Social Sciences for Windows (SPSS, Chicago, Ill). All ADC
data were recorded in Mean ± SD (×10-3 mm2/s) form.
Mann–Whitney U-test was performed to compare the
quantitative ADC value of benign and malignant thyroid
nodules. A value of p < .05 was considered significant. In
addition, receiver operating characteristic (ROC) curve
was constructed to determine a cutoff value for diffe-
rentiating benign and malignant thyroid lesions. Receiver
operating characteristic (ROC) curves were constructed
and areas under the ROC curve (Az) were computed using
MedCalc version 10.2.0.0 (http://www.medcalc.com/).
Results
MRI results revealed that among those 42 cases of lesions
in the thyroid, 10 were located in the left lobe of thyroid
gland, 16 of were in the right lobes, 14 had lesions on both
lobes and 2 lesions were in thyroid isthmus. For those
with lesions on both lobes, one was randomly chosen
(matched with pathology) for ADC measurements. Mean
major diameter of the benign and malignant lesions were
3.63 cm and 2.55 cm respectively. Historical findings
confirmed there were 28 benign cases and 14 malignant
lesions. Independent of malignancy, thyroid lesions oc-
curred more frequently in female than in male (Table 1).
Parameters for differentiating lesion malignancy
Using histology results to group the ADC values we
found that the ADC values were significantly different
(p < 0.001) between benign and malignant lesions for the
ADC values computed for b = 300 s/mm2. Mean ADC
value for benign group (Figure 1) is much higher than
that for malignant group (Figure 2), with the values of
Table 1 Historical results and patient characteristics
Histological categories Number (%) Mean age (yrs) Female (%) Mean maximum diameter (cm)
Benign 28(66.7) 41.7 21(75) 3.63 ± 0.37
Thyroid adenoma 20(47.6) 42.6 15(53.6) 3.53 ± 0.25
Nodular goiter 6(14.3) 39.3 5(17.9) 3.95 ± 0.65
Hashimoto's thyroiditis 2(4.8) 35.6 1(3.6) 3.71 ± 0.11
Malignant 14(33.3) 45.3 11(78.6) 2.55 ± 0.41
Thyroid papillary carcinoma 11(26.2) 41.9 9(64.4) 2.73 ± 0.54
Follicular thyroid cancer 2(4.8) 49.1 1(7.1) 1.7 ± 0.13
Atypical hyperplasia 1(2.4) 45 1(7.1) 2.3
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respectively. However, no significant difference was ob-
served between the two groups for the ADC values
obtained using b = 500 s/mm2 or 800 s/mm2 (Table 2).
Sensitivity, specificity and AUC were also compared
among three different b-factors. Highest sensitivity and
AUC was observed at b-factor of 300 s/mm2 (Table 3).
We also selected four variables (age, sex, ADC value,
max nodular diameter) as independent variables to per-
form logistic regression analysis. Odds ratios (and 95%
CIs) based on the logistic regression model were also
calculated. The results obtained from the logistic regres-
sion model showed that ADC values obtained with a b
factor of 300 s/mm2 (OR = 4.76, p <0.001) and max
nodular diameter (OR = 3.22, p = 0.034) were the two
most discriminative independent variables for differen-
tiating between benign and malignant lesions (Table 2).Figure 1 A 44-year-female patient with right lobe thyroid adenoma; (
hemorrhage in the right lobe (short thick arrow). Long thin arrow show
lesion with homogenous enhancement. (E-G) showed ADC value obtained
respectively. ROIs were placed in the lesion at right upper area to avoid theROC analysis
Furthermore, a Receiver Operator Characteristic (ROC)
curve was computed for the ADC values obtained from
DWI scans using b = 300 s/mm2. We determined a cut-
off point from the ROC curve that would differentiate
benign from malignant lesions. The area under the ROC
curve was 0.876. When we selected a cutoff ADC value
of 2.17 × 10-3 mm2/s, sensitivity and specificity was
found to be 76.5% and 100% respectively (Figure 3).
Discussion
To date, only a few studies have focused on the use of
DWI in evaluating thyroid disease. Tezuka [14] et al.
used both routine T1WI, T2WI and DWI techniques to
diagnose thyroid diseases (Graves’ disease, sub-acute
thyroiditis and Hashimoto's disease). Although no ob-
vious difference using T1WI and T2WI were detectedA-C) Non-contrast and contrast transversal images showed a
s the lesion. (D) Coronal images showed the well-circumscribed
from ADC map with b factors of 0, 300, 500 and 800 s/mm2,
hemorrhage area. (H) ADC map generated at b-factor of 300 s/mm2.
Figure 2 A-36-year-female patient with thyroid papillary carcinoma at left lobe and isthmuses is shown. (A-B) Non-contrast and contrast
transversal images showed abnormal signal at left lobe and isthmus with multiple cysts (long arrows). (C-E) showed ADC value measured from
ADC map with b factors of 300, 500 and 800 s/mm2, respectively. (F) ADC map generated at b-factor of 300 s/mm2.
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of Graves’ disease was found much higher than that of
sub-acute thyroiditis or Hashimoto's disease. An ADC
value of 1.82 × 10-3 mm2/s was suggested as the cutoff
point to diagnose Graves’ disease (Sensitivity 75% and
Specificity 80%). DWI has emerged as a potential new
noninvasive technique that can provide more quantita-
tive information on thyroid lesions and help make cli-
nical differential diagnosis.
MR technique
Diffusion weighted MR imaging can be done with single
shot or multi-shot. Wang and Adel Razek [11,15] applied
single-shot multisection echo-planar technique, using b
values of 0, 500 and 1000 s/mm2 respectively. This se-
quence is characterized by a train of gradient echoes with
a short echo time image and good signal-to-noise ratioTable 2 Association between parameters and disease propert
Benign group (n = 28) Malig
Age (yrs) 41.7
Sex (Female %) 21(75)
Max nodular diameter (cm) 3.63 ± 0.37
ADC values [mm2/s]
b-0,300 2.37 ± 0.47
b-0,500 1.87 ± 0.25
b-0,800 1.68 ± 0.25
*p value reflected from logistic analysis.(SNR), but it was associated with more magnetic suscepti-
bility artifacts. Tezuka [14] et al., used a fast spin echo se-
quence for diffusion-weighted imaging to avoid magnetic
susceptibility artifacts, but not only was the imaging time
increased but the SNR was also decreased.
In this study, we used a STIR (Short TI Inversion
Recovery) fat suppressed SE EPI (Spin-Echo Echo Planar
Imaging) sequence. STIR is a very robust fat suppression
technique with minimal artifacts. It has low sensitivity to
magnetic field inhomogeneities or susceptibility effects
and thus improves image quality. It also produces a slight
T1-weighted background suppression but does not affect
the accuracy of the images. EPI is the fastest acquisition
method and it only requires 30 ms ~ 100 ms to collect
one image which helps in reducing most physiological
movement artifacts [16]. Furthermore, short TE time of
60 ms was used to reduce T2* effect in our study. Thus,y
nant group (n = 14) P value* OR 95% CI
45.3 0.79 0.62 0.26, 2.59
11(78.6) 0.61 0.50 0.16, 1.54
2.55 ± 0.41 0.034 3.22 1.27, 6.76
1.49 ± 0.60 <0.001 4.76 1.56, 9.89
1.61 ± 0.45 0.138 1.01 0.3, 1.81
1.41 ± 0.34 0.059 0.091 0.03, 0.73
Table 3 Sensitivity, specificity and AUC of the use of
mean ADC value as calculated based on 3 different
b-values for differentiating benign from malignant
thyroid lesions
b = 0,300 b = 0,500 b = 0,800
AUC 0.88(0.77–0.97) 0.63(0.47–0.77) 0.63(0.46–0.77)
Criterion [10-3 mm2/s] >2.17 >1.74 >1.65
Sensitivity % 76.5 67.9 53.6
Specificity % 100 64.3 71.4
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tissue ADC values.
The b-factor in the DWI was an important factor for
image quality. We obtained diffusion-weighted MR images
with different b factors simultaneously to avoid misre-
gistration in computing the different ADC values. Higher
b-values produce more diffusion weighting and therefore
higher contrast between thyroid lesions and normal tissue.
However, higher b value also leads to increased signal at-
tenuation and usually required more averages to compen-
sate for the SNR. Higher b-values also produce more
susceptibility distortions and could increase the noise in
the DWI images because the distortions are different de-
pending on the gradient directions. In addition, different
tumors within different organs or tissues may be more
sensitive to different b-values. In this study, we applied an
SE EPI diffusion imaging with b-factors of 300, 500 and
800 s/mm2. Our results showed that a b-factor of 300
s/mm2 was sufficient to obtain high quality ADC valuesFigure 3 Receiver operating characteristic (ROC) curve with the
ADC value (computed from DWI with b = 0 and 300 s/mm2)
used for differentiating benign from malignant thyroid lesions.and it was also the one with had a high sensitivity and ac-
curacy for differentiating benign and malignancy. These
results are consistent with Bozgeyik’s [17] results.
Pathological mechanism of ADC values in thyroid lesions
In our study we were able to use the most reliable refe-
rence for malignancy which was based on the histopath-
ology of a thyroidectomy. Our results showed a significant
difference in the ADC value between benign and malignant
thyroid lesions, with ADC values in benign lesions being
higher than malignant lesions (2.37 ± 0.47 × 10-3 mm2/s vs.
1.49 ± 0.60 × 10-3 mm2/s) at the b factor of 300 s/mm2.
These results are consistent with other similar studies
[17-19]. Diffusion weighted imaging provides more in-
formation on the microstructure of tissues and their
physiological processes. Changes in the distributions of
intracellular organelles and macromolecules in the tis-
sues affect the random motion of water protons. ADC
values of tissues vary according to its cellularity and
histopathology. Anderson [20]’s study showed that ma-
lignant lesions in thyroid glands was characterized by
compact cellularity which increased the nucleocyte-
cytoplasmic ratio (NCR). These microscopic patho-
logical changes results in the reduction of extracellular
space which limits diffusional motion of water protons.
Reduced ADC values are presented as high signal on
DWI sequences.
Abdel’s [21] study demonstrated that when selecting
ADC value of 0.98 × 1.0-3 mm2/s as a cutoff point to dif-
ferentiate benign and malignant lesions, the sensitivity
and specificity was 97.5% and 91.7%, respectively. The
accuracy was up to 98.9%. In this study a single pair of b-
values (0, 1000 s/mm2) were studied. Although we also
looked at the ADC values obtained using higher b-values
(0,800 s/mm2), we did not detect any useful threshold at
the higher b-values. Abdel’s study included a variety of
cervical lymph nodes whereas our study focused on the
thyroid. Lesion heterogeneity might have accounted for
the differences in sensitivity. It was also suggested that the
ADC values of benign thyroid nodule may vary according
to the complex composition within the nodule (colloid,
tiny necrosis and cystic change, hemorrhage, fibrosis and
calcium). ADC values were highest in thyroid cysts since
it contained colloid cyst made of serous or concentrated
thyroglobulin. Conversely, increasing NCR and grit-like
calcification mainly lead to a decrease of ADC values in
papillary thyroid carcinoma.
Bozgeyik [17] also studied thyroid nodules with DWI at
lower b-values. Bozgeyik [17] also found that a b-factor of
300 s/mm2 was the most useful for differentiating benign
or malignant lesions. In Bozgeyik’s study 3 b-value pairs
were used to computed the ADC (0, 100 s/mm2), (0,
200 s/mm2) and (0, 300 s/mm2). We expanded on these
results and investigated ADC values obtained using larger
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whereas in Bozgevik’s study less than 5% of the nodules
were malignant. In their study, malignancy was deter-
mined using FNAB whereas in our study we have used
pathology results from thyroidectomy, a more accurate
reference. Erdem [19] also suggested that tiny calcification
was closely correlated with the reduction of ADC values
in thyroid malignancy.
However, in Weidekamm’s [22,23] study, the opposite
result was reported. ADC values were predominantly
higher in malignant thyroid nodules than that in benign
nodules with values equal or more than 2.25 × 10-3 mm2/s.
The higher ADC values may be due to the over production
of thyroprotein follicle in malignant thyroid nodules which
do not restrict the diffusion of the water protons.
ADC values has been used as a quantitative parameter
for differentiating benign and malignant lesions [24]. The
ADC values depend on many factors such as tissue micro-
structure, necrosis, presence of macromolecules and also
perfusion phenomenon. When compared to benign le-
sions, abnormal blood perfusion is more prevalent in ma-
lignant lesions and ADC values will be affected by both
blood perfusion and extracellular space. Unlike some
other studies [17], in the current study, we chose three dif-
ferent b factors all over 300 s/mm2 since ADC value
would better reflect the true water diffusion in the tissue
with larger b factors. However, there was no significant
difference in ADC value between benign and malignant
lesions when the b factors were 500 s/mm2 and 800
s/mm2. Delormere [25] demonstrated that malignant le-
sions usually do not have a complete basal membrane of
blood vessel which enhances the molecular exchange in
the capillary bed. ADC values could be influenced by both
blood perfusion and extracellular space. In thyroid malig-
nancy, increased blood perfusion increases the apparent
speed of the diffusing water protons while narrow extra-
cellular space will restrict its movement. Although at
higher b-values the sensitivity to perfusion is reduced, our
results show no difference in ADC values between benign
and malignant groups with b-values of 500 s/mm2 or
800 s/mm2. The ADC values obtained using the lower
b-value of 300 s/mm2 is most likely affected by both
perfusion and diffusion effects. It is possible that the
discriminatory effect of this lower 300 s/mm2 reflect a
combination of altered vascularity and changes in cellu-
lar composition that characterizes malignancy.
Fine-needle aspiration biopsy (FNAB) cytology can give
4 different results: benign, malignant, suspicious and non-
diagnostic. No definite diagnosis is possible for the two
categories of suspicious and non-diagnostic. Although
FNAB is commonly used to screen for malignancy, a
unique approach in this study is that we used histological
results from thyroidectomy as the standard reference for
distinguishing benign and malignant lesions. Based onfinal histological results, we were able to obtain a definite
diagnosis of each lesion. ROC curves and cut off point for
b-values are more accurate in this approach.
There are still some limitations in this study. First, the
relatively small number (33.3%) of the malignant nodules
somehow limits the statistical power. This study needs
to be expanded further with a larger number of patients.
B-values should be extended to lower values and higher
ranges to verify that 300 s/mm2 is an optimal value. Se-
cond, thyroid nodules less than 10 mm were not in-
cluded in this study. Improvement in the software of
diffusion-weighted MR imaging will help in the detec-
tion of smaller lesions in future studies. Third, we have
not studied the correlation of ADC values with subtypes
of thyroid lesions such as cysts from hemorrhagic no-
dules because of the small number which would reduce
its statistical power.
Conclusion
In conclusion, diffusion-weighted MR imaging is a rela-
tively new and non-invasive approach to assess thyroid
lesions. ADC values seem to be able to differentiate
benign from malignant thyroid disease. Further studies
should be performed to expand the utility of DWI in
thyroid lesions.
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